Ameriprise Financial Inc Veracyte, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Veracyte, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 90,454 shares of VCYT stock, worth $3.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

90,454

Holding current value

$3.35 Million

% of portfolio

0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$21.0 - $35.25 $1.9 Million - $3.19 Million	90,454 New	90,454 $3.08 Million
Q4 2023 Feb 14, 2024	SELL	$19.72 - $28.68 $2.9 Million - $4.21 Million	-146,910 Reduced 86.88%	22,179 $610,000
Q3 2023 Nov 14, 2023	SELL	$22.33 - $29.92 $111,873 - $149,899	-5,010 Reduced 2.88%	169,089 $3.78 Million
Q2 2023 Aug 14, 2023	BUY	$20.96 - $26.99 $1.04 Million - $1.34 Million	49,558 Added 39.79%	174,099 $4.43 Million
Q1 2023 May 15, 2023	BUY	$20.58 - $27.89 $81,558 - $110,528	3,963 Added 3.29%	124,541 $2.78 Million
Q4 2022 Feb 14, 2023	SELL	$15.31 - $29.94 $216,345 - $423,082	-14,131 Reduced 10.49%	120,578 $2.86 Million
Q3 2022 Nov 14, 2022	SELL	$16.58 - $27.9 $595,537 - $1 Million	-35,919 Reduced 21.05%	134,709 $2.24 Million
Q2 2022 Aug 15, 2022	SELL	$15.45 - $29.52 $80,401 - $153,622	-5,204 Reduced 2.96%	170,628 $3.4 Million
Q1 2022 May 16, 2022	SELL	$21.94 - $42.51 $528,710 - $1.02 Million	-24,098 Reduced 12.05%	175,832 $4.85 Million
Q4 2021 Feb 14, 2022	BUY	$36.09 - $53.79 $5.87 Million - $8.74 Million	162,535 Added 434.64%	199,930 $8.24 Million
Q3 2021 Nov 15, 2021	SELL	$35.62 - $52.97 $357,660 - $531,871	-10,041 Reduced 21.17%	37,395 $1.74 Million
Q2 2021 Aug 16, 2021	BUY	$32.94 - $56.62 $1.41 Million - $2.42 Million	42,784 Added 919.69%	47,436 $1.9 Million
Q1 2021 May 17, 2021	BUY	$44.47 - $81.38 $206,874 - $378,579	4,652 New	4,652 $250,000
Q3 2020 Nov 16, 2020	SELL	$26.73 - $35.67 $1.83 Million - $2.44 Million	-68,410 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$19.49 - $28.11 $22,744 - $32,804	1,167 Added 1.74%	68,410 $1.77 Million
Q1 2020 May 15, 2020	SELL	$16.13 - $30.17 $142,314 - $266,189	-8,823 Reduced 11.6%	67,243 $1.64 Million
Q4 2019 Feb 14, 2020	BUY	$20.78 - $29.99 $376,014 - $542,669	18,095 Added 31.21%	76,066 $2.12 Million
Q3 2019 Nov 14, 2019	SELL	$23.87 - $30.93 $340,505 - $441,216	-14,265 Reduced 19.75%	57,971 $1.39 Million
Q2 2019 Aug 14, 2019	BUY	$22.1 - $28.56 $1.6 Million - $2.06 Million	72,236 New	72,236 $2.06 Million
Q1 2019 May 15, 2019	SELL	$12.0 - $25.76 $1.14 Million - $2.45 Million	-94,980 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$9.15 - $14.85 $869,067 - $1.41 Million	94,980 New	94,980 $1.2 Million

Others Institutions Holding VCYT

# of Institutions

307

Shares Held

81.3M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.65B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Veracyte, Inc. Transaction History